Navigation Links
Two UCSF Scientists to Receive Prestigious Dementia Research Honor
Date:2/18/2010

Two UCSF scientists have been selected for the American Academy of Neurology’s prestigious Potamkin Prize, for their “outstanding achievements” in research on dementias.

(Vocus) February 17, 2010 -- Two UCSF scientists have been selected for the American Academy of Neurology’s prestigious Potamkin Prize, for their “outstanding achievements” in research on dementias.

Bruce Miller, MD, W. & Mary Margaret Clausen Distinguished Professor of Neurology, and Lennart Mucke, MD, Joseph B. Martin Distinguished Professor of Neuroscience and director of the Gladstone Institute of Neurological Disease, will receive the honor for their major contributions to the understanding of the causes of, and treatment strategies for, frontotemporal lobar degeneration, Alzheimer’s disease and related diseases.

They will receive the prize on April 15, 2010 at the AAN’s annual meeting. The $100,000 prize is to be used for continuing research on dementias.

As director of UCSF’s Memory and Aging Center, Miller oversees a program that provides clinical care and conducts clinical research on all forms of dementia. The Center carries out neuroimaging studies aimed at improving diagnoses of the various forms of dementia, understanding the progression of the diseases and studying the impact of experimental drugs on the conditions. For more than a decade, he and Mucke, a basic researcher based at the Gladstone Institutes, have worked closely to build one of the premier dementia research programs in the world.

Miller has a special interest in the behavioral effects of dementia, notably those seen in FTLD, once commonly known as Pick’s disease. Along with Alzheimer’s disease, FTLD is the leading cause of dementia in patients under 65 years.

FTLD presents as several forms -- behavioral FTLD is characterized by emotional deficits, impulsivity and a lack of empathy; semantic dementia is marked by a gradual loss of the meaning associated with words; and progressive non-fluent aphasia is impacts patients’ production of language.

Patients with the behavioral form of the disease frequently exhibit unexpected artistic and musical talents that may initially intensify as the disease progresses, a phenomenon that Miller has documented. This trait is attributed to the strengthening and remodeling of parts of the brain linked to creativity, compensating for damaged areas associated with language.

When Miller started studying FTLD more than 25 years ago, the mantra in neurology was “Don’t pick Pick’s disease,” he says. At the time, the disease was viewed as a “rare, biologically obscure illness that could not be diagnosed at the bedside.”

Today, thanks in part to Miller and colleagues’ pioneering research, neurologists are able to distinguish FTLD from Alzheimer’s disease in its earlier stage. Promising advances have been made in the genetics and molecular pathology of the disorder. Recent developments include testing therapies that target the genetic cause for FTLD, a milestone that Miller describes as “the most exciting work” he has ever undertaken.

Author of the book “The Human Frontal Lobes” and the medical director of the John Douglas French Foundation for Alzheimer’s Disease, Miller works closely with UCSF Nobel laureate Stanley Prusiner, MD, director of the UCSF Institute for Neurodegenerative Diseases and, himself, the 1991 recipient of the Potamkin Prize. In the early 2000s, they conducted a clinical trial using an experimental drug to treat the dementia known as Creutzfeldt-Jakob disease (CJD).

Prusiner won the Nobel Prize in Physiology or Medicine in 1997 for his discovery of prions, a class of proteins that causes CJD in humans and “mad cow” disease in cattle. The discovery has informed research into the role of misprocessed proteins in more common brain diseases, including Alzheimer’s and Parkinson’s disease.

Mucke, a basic researcher, is best known for his role in instigating a turnaround in the direction of research into Alzheimer’s disease, from an almost exclusive focus on morphological abnormalities in the brain to a focus on the molecular processes that cause the dysfunction of neural networks in the brain.

Ten years ago, many scientists believed the condition was caused by the accumulation of amyloid plaques in the brain. Mucke and colleagues showed that a minuscule constituent of these plaques, known as amyloid-beta peptide, can disrupt the function of brain cells independent of plaques, thus narrowing the whereabouts of the disease culprit from the “haystack” to the “needle.”

Mucke has also generated genetically engineered mice to pinpoint the key molecules and proteins that contribute to the progression of Alzheimer’s thereby setting the stage for new therapies to combat the disease. Using mouse models of Alzheimer’s disease, Mucke and colleagues have successfully prevented the disease progression and even reversed cognitive impairments.

The Potamkin Prize, says Mucke, is a wonderful reinforcement of the synergism” between himself and Miller. “Working hand-in-hand, we have developed innovative translational programs for the investigation and treatment of dementia and related disorders.”

Miller concurs, describing the Potamkin Prize as “the highlight of my academic career.”
The Gladstone Institutes is a nonprofit, independent research and educational institution, consisting of the Gladstone Institute of Cardiovascular Disease, the Gladstone Institute of Virology and Immunology and the Gladstone Institute of Neurological Disease. Independent in its governance, finances and research programs, Gladstone shares a close affiliation with UCSF through its faculty, who hold joint UCSF appointments.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

Related Links:

Bruce Miller, UCSF Memory and Aging Center
http://tinyurl.com/yervum8

Lennart Mucke, Gladstone Institute for Neurological Disease
http://www.gladstone.ucsf.edu/gladstone/site/mucke/

UCSF Neuroscience Building to drive advances against brain diseases
http://news.ucsf.edu/releases/ucsf-neuroscience-building-to-drive-advances-against-brain-diseases/

Contact:
Jennifer O’Brien (415) 476-2557
E-mail:   jobrien (at) pubaff.ucsf (dot) edu
Web:    www.ucsf.edu

###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3620324.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Two UCSF Scientists to Receive Prestigious Dementia Research Honor
(Date:4/29/2016)... , ... April 29, 2016 , ... ... by the Accreditation Council for Graduate Medical Education (ACGME) that it has received ... is the first accreditation of three residency programs that Memorial is currently pursuing, ...
(Date:4/29/2016)... ... April 29, 2016 , ... Our bodies are bombarded ... to confront and deal with these stressors is to adopt a more healthful diet, ... for you. Risa Groux, a certified Holistic Nutritionist and the creator of the Newport ...
(Date:4/29/2016)... ... April 29, 2016 , ... The American ... productivity, stability, even security. Most importantly, employees are the single most important asset ... American workers so unhappy? , Just under half of American workers are emotionally ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart is celebrating its ... location in the Exchange Furniture Mall at 112 Vilseck Road in Fort Stewart. There ... TV. Plus attendees will have the opportunity to meet general dentists Thomas Richards, DDS, ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... The global  gamma oryzanol ... by 2022, according to a new report by ... a healthy lifestyle is expected to drive product ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... treatment expenditure has urged consumers to switch to ...
(Date:4/26/2016)... , April 26, 2016 Diplomat Pharmacy, Inc. ... Jennifer Hagerman , Pharm D., to Vice President ... role at Diplomat, Hagerman will continue to lead and ... that delivers custom education and training to Diplomat employees ... pharmacy industry. Diplomat University also houses the quality assurance ...
(Date:4/26/2016)... April 26, 2016 US demand for ... expand 4.9 percent annually to $27.6 billion in ... facilities to decrease rates of healthcare-associated infections (HAIs) ... equipment, and services.  Although declining, the overall rate ... targeted levels set by the CDC.  Recent statistics ...
Breaking Medicine Technology: